Qvents
Discussion forum for Pharma Quality events, Regulatory Actions
Warning letters, 483s, Recalls, Import Alerts, Audit observations
Home
About Us
Contact Us
Expert Panel
Tags
Qvents
Warning Letters
483s
Recalls
Import Alerts
Quality Insights
Tags
Forums
Learning Resources
Upcoming Trainings
Training Archives
Guidelines
Pharma Jobs
Job Openings
Post a Job
Jobs posted by me
Users & Profiles
News
Login/Register
Individual
Company
Home
About Us
Contact Us
Expert Panel
Tags
Qvents
Warning Letters
483s
Recalls
Import Alerts
Quality Insights
Tags
Forums
Learning Resources
Upcoming Trainings
Training Archives
Guidelines
Pharma Jobs
Job Openings
Post a Job
Jobs posted by me
Users & Profiles
News
Login/Register
Excipients related
Qvents
1 minute read
Uncategorized
Home
Guidelines
Excipients related
Updated on October 11, 2023
Home
Guidelines
Excipients related
Updated on October 11, 2023
Excipient Risk Assessment (Europe)
:
Guidelines of 19 March 2015 on the formalised risk assessment for ascertaining the appropriate good manufacturing practice for excipients of medicinal products for human use ( EC 2015/C 95/02)
PIC/S Document:
Guidelines On The Formalised Risk Assessment For Ascertaining The Appropriate Good Manufacturing Practice For Excipients Of Medicinal Products For Human Use
IPEC Europe
(International Pharmaceutical Excipients Council Europe)-
How to do document on European Commission Guidelines on the formalised risk assessment for ascertaining the appropriate good manufacturing practice for excipients of medicinal products for human use
IPEC-PQG
Good Manufacturing Practices Guide for Pharmaceutical Excipients (version 5, 2022).
IPEC Guidelines
IPEC Europe
(International Pharmaceutical Excipients Council Europe) –
Resources (on Pharmaceutical Excipients)
IPEC Americas
(International Pharmaceutical Excipients Council Europe) –
Document Depot
(For several resources on Excipients (Standards, Test Methods, Discussion papers).
IPEC Americas –
S. Drug Master File Guide For Pharmaceutical Excipients
(Download from Document Depot)
USFDA
Using the Inactive Ingredient Database (IID) Guidance for Industry
;
FDA Guidance
;
Search the IID
Share:
Facebook
LinkedIn
Twitter
Search Posts
Latest Posts
USFDA 483 Cites Piramal Pharma for Investigation Deficiencies, Procedural Non-Compliance
March 13, 2025
Contamination Control and Data Integrity Issues: Granules India Receives USFDA Warning Letter
March 7, 2025
Janssen’s Korea Vaccine Unit USFDA 483 Cites Aseptic Operations Not in Control
February 26, 2025
Facility Registration Violations, Refusal of Inspection: Jagsonpal Issued Warning letter
February 22, 2025
Purified Water System Qualification and Control: USFDA Expectations
February 11, 2025